AMC Global Media Inc.
No SEC Form 4 filings for $AMCX in the last 30 days.
See all $AMCX insider activity →UBS raised its price target for AMC Networks (AMCX) to $10 from $6 but kept a Sell rating. The change reflects higher expected cash generation and visibility from AMC’s Walking Dead licensing deal with Netflix. UBS forecasts adjusted operating income of $374M in 2027 and $250M in 2028, and free cash flow of $240M and $172M.
AMC Networks (NASDAQ: AMCX) shares rose about 13% after the company announced a roughly $500M co-exclusive licensing deal with Netflix tied to The Walking Dead. The article also cites improved 2026 revenue guidance to about $2.4–$2.45B and discusses valuation, debt, and technical levels around $10 support and $11.25 resistance.
AMC Global Media (AMCX) shares rose about 15% to $11.20 after earnings. The company said it raised full-year revenue and free cash flow guidance, citing a $500m, five-year Netflix licensing deal tied to The Walking Dead universe. Q2 revenue was $547.5m, with a $21.9m loss versus prior-year profit.
Over the past 7 days, alphai's AI scored 1 news story mentioning AMCX (AMC Global Media Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent AMCX coverage spans financial news, mergers & acquisitions and market movers.
Analyst target increase plus Sell stance frames upside as limited by linear TV secular decline and moderating streaming growth.
The reported Netflix licensing deal and higher 2026 revenue guidance are positioned as catalysts for earnings and deleveraging, driving a sharp rerating and momentum.
The Netflix Walking Dead licensing contract is the key incremental catalyst, improving cash visibility despite ongoing losses and a still-heavy net-debt load.
The disclosed distribution expansion and Netflix licensing economics are a near-term positive catalyst, likely supporting higher revenue visibility and sentiment.
AMC+ gains first-time access to the original series and broader global availability, potentially improving retention and acquisition in markets where AMC+ operates.
alphai scores every news story that mentions AMCX with an AI model for sentiment and relevance, and aggregates insider trades from AMC Global Media Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
UBS raised its price target for AMC Networks (AMCX) to $10 from $6 but kept a Sell rating. The change reflects higher expected cash generation and visibility from AMC’s Walking Dead licensing deal with Netflix. UBS forecasts adjusted operating income of $374M in 2027 and $250M in 2028, and free cash flow of $240M and $172M.
3 min readAMC Networks (NASDAQ: AMCX) shares rose about 13% after the company announced a roughly $500M co-exclusive licensing deal with Netflix tied to The Walking Dead. The article also cites improved 2026 revenue guidance to about $2.4–$2.45B and discusses valuation, debt, and technical levels around $10 support and $11.25 resistance.
6 min readAMC Global Media (AMCX) shares rose about 15% to $11.20 after earnings. The company said it raised full-year revenue and free cash flow guidance, citing a $500m, five-year Netflix licensing deal tied to The Walking Dead universe. Q2 revenue was $547.5m, with a $21.9m loss versus prior-year profit.
6 min readAMC Networks (AMCX) shares rose about 17% after the company announced a distribution deal with YouTube TV and a content licensing agreement with Netflix. The Netflix deal grants co-exclusive global streaming rights to the “Walking Dead Universe” and is expected to generate $500 million in fees over five years. Wells Fargo raised its AMCX price target to $11 from $10.
4 min readNetflix and AMC Global Media have signed a multi-year global licensing agreement that will make the entire "The Walking Dead" franchise available across both companies' streaming platforms, expanding Netflix's international rights while bringing the original series to AMC+ for the first time. “Audiences have discovered and loved "The Walking Dead" on Netflix for nearly 15 years and the show continues to attract new fans,” said Lori Conkling, Vice President of Licensing at Netflix.
4 min readAMC has struck a massive global licensing deal with Netflix, securing a $500 million future for The Walking Dead universe. The pact reshapes where audiences will find the post-apocalyptic saga. It follows years of fragmented streaming rights and is a strategic pivot for both entertainment giants.
2 min readNetflix has officially renewed its licensing deal for The Walking Dead, securing the rights to the entire zombie franchise in a massive five-year, $500 million agreement with AMC Global Media, Deadline reported. This move cements the series as a cornerstone of the streaming landscape. The deal covers a staggering 371 episodes, including the original series and its six spinoffs.
2 min readAMC Global Media and Netflix agreed to a five-year, $500 million co-exclusive streaming licensing deal for The Walking Dead Universe starting in 2027. Netflix will stream the original series and spinoffs on Netflix, while AMC Global Media will add the original series to AMC+ for the first time. Timing for each title depends on existing licensing expirations.
4 min readNetflix and AMC Networks (AMC Global Media) announced a multi-year global streaming licensing deal for the full The Walking Dead Universe. Netflix will expand rights beyond the US, adding UK, Italy, Australia and New Zealand. From 2027, all seven series will stream globally on Netflix, with the original also on AMC+ early next year. The deal covers 371 episodes.
3 min readVariety reported Netflix and AMC Global Media agreed to a $500 million co-exclusive global licensing pact for The Walking Dead franchise and six spinoffs to stream on Netflix and AMC+. Existing licenses expire, with new licenses starting on different dates and in multiple territories from 2027. AMC+ will carry the original series for the first time early next year.
3 min read
